Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A dry eye disease and pharmaceutical technology, applied in the field of medicine, can solve the problems of large damage to eye tissue and drug resistance, and achieve the effect of clear curative effect and good safety.
Inactive Publication Date: 2014-02-05
顾克斌
View PDF1 Cites 6 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Because the tissues of the eye are more sensitive, these drugs have greater damage to the eye tissues, and often cause problems of drug resistance
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
experiment example
[0012] Diagnostic criteria: eye dryness, foreign body sensation, fatigue, red eyes, photophobia, burning sensation, eye soreness, eye pain; tear function test: tear secretion test I (SCHERMER I) <10mm, tear film breakup time (BUT) <10s. Exclude photonous anemia, no lacrimal gland, lacrimal duct obstruction caused by extensive ocular surface damage due to neurological disorders, uncontrolled systemic diseases, wearing contact lenses, recent history of eye surgery or trauma, etc. Systemic antihistamines, anticholinergics or other ophthalmic drugs are contraindicated during the medication.
[0013] Fifty patients with dry eye syndrome who met the above diagnostic criteria were selected, including 25 males and 25 females, with an average age of 37 years.
[0014] Use the decoction prepared in Example 1 for treatment, 2 times a day, each oral administration of 50 milliliters. One week of treatment is a course of treatment. Review after 1 week of treatment. The Schirmer test and...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a medicine for treating dry eye syndromes. The medicine for treating dry eye syndromes comprises the following components in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of dried ginger, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of angelica dahurica, 5-15 parts of inula flower, 10-30 parts of cowherb seed, 1-15 parts of motherwort fruit, 10-20 parts of radix sileris, 15-30 parts of capillary artemisia, 20-30 parts of myrobalan, 1-20 parts of fenugreek, 1-20 parts of celandine, 10-25 parts of rhizoma imperatae, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of semen pharbitidis, 15-20 parts of lychee seed, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of folium rhododendri daurici, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of white mulberry root-bark, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon euryale seed and 10-25 parts of Chinese azalea flower. All the components of the medicine for treating dry eye syndromes are natural materials, so that the medicine for treating the dry eye syndromes has good safety and clear curative effect and is suitable for large-scale application in clinic.
Description
technical field [0001] The invention relates to the field of medicine, in particular to a medicament for treating dry eye. Background technique [0002] Dry eye syndrome refers to a group of diseases that cause eye discomfort symptoms due to tear film instability and ocular surface damage caused by abnormal tear quantity or quality or abnormal tear fluid dynamics. The clinical manifestations are dryness, foreign body sensation, burning Sensation, itching, photophobia, red eyes, blurred vision, fluctuations in vision and visual fatigue. With the development of social economy and the improvement of people's living standards, the incidence of dry eye tends to increase and tend to become younger. At present, eye drops and the like are used clinically to treat dry eye syndrome. Since the tissues of the eye are relatively sensitive, these drugs have relatively large damage to the eye tissues, and often cause problems of drug resistance. Contents of the invention [0003] The ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.